|   Bleeding+  |       Bleeding−  |       p  |    |
|   Age  |       62.21 ± 12.68  |       62.78 ± 11.92  |       0.78  |    
|   Male (%)  |       56.40%  |       60.40%  |       0.37  |    
|   Diabetes Mellitus (%)  |       33%  |       39.40%  |       0.71  |    
|   Hypertension (%)  |       71.80%  |       81.30%  |       0.11  |    
|   Smoke (%)  |       43.60%  |       41.40%  |       0.46  |    
|   FH of CAD (%)  |       12.80%  |       12.40%  |       0.55  |    
|   Dyislipidemia (%)  |       35.90%  |       47.70%  |       0.1  |    
|   Stable angina (%)  |       5.10%  |       13.00%  |       0.34  |    
|   Heart failure (%)  |       5.10%  |       7.70%  |       0.56  |    
|   Previous AMI (%)  |       43.60%  |       37.70%  |       0.29  |    
|   Previous CABG (%)  |       10.30%  |       16.00%  |       0.24  |    
|   Previous PCI (%)  |       25.60%  |       25.40%  |       0.55  |    
|   SAP (mmHg)  |       133.41 ± 30.94  |       132.74 ± 28.51  |       0.89  |    
|   Hb (g/dL) (median)  |       13.1 ± 2.69  |       13.84 ± 1.88  |       0.02  |    
|   Cr (mg/dL) (median)  |       1.51 ± 1.57  |       1.29 ± 0.83  |       0.14  |    
|   Troponin (higher/median) (ng/dL)  |       5.46 ± 9.96  |       6.31 ± 34.95  |       0.88  |    
|   EF (%) (median)  |       47.97 ± 18.74  |       39.52 ± 24.42  |       0.04  |    
|   AAS (%)  |       94.90%  |       95.90%  |       0.9  |    
|   B-blockerr (%)  |       61.50%  |       69%  |       0.6  |    
|   Enoxaparin (%)  |       56.40%  |       71.60%  |       0.03  |    
|   GPI IIb/IIIa (%)  |       17.90%  |       11.80%  |       0.26  |    
|   Clopidogrel (%)  |       82.10%  |       57.80%  |       0.003  |    
|   ACE inhibitor (%)  |       38.50%  |       50.10%  |       0.11  |    
|   Statin (%)  |       69.20%  |       81.90%  |       0.04  |